Ebola Virus Disease: Unravelling the Pathophysiology

Introduction

Ebola virus disease (EVD), caused by the Ebola virus, is a rare but severe illness that can have devastating consequences. In this comprehensive blog, we delve into the intricate pathophysiology of EVD, exploring its transmission, symptoms, complications, and prevention strategies.

Table of Contents

1. Overview of Ebola Virus Disease
   • Definition and Severity
   • Modes of Transmission
   • Early Symptoms
2. The Viral Culprit: Ebola Virus
   • Filoviridae Family
   • Genus Ebolavirus: Species Breakdown
3. Pathogenesis: How Ebola Takes Hold
   • Viral Replication and Cell Necrosis
   • Immune System Suppression
   • Organ Failure
4. Clinical Manifestations and Complications
   • From Fever to Haemorrhagic Fever
   • Long-Term Effects
5. Diagnosis and Treatment
   • Diagnostic Tests
   • Supportive Care
   • Monoclonal Antibody Treatments
6. Preventing Ebola
   • Vaccines and Their Role
   • Hygiene Practices
   • Community Engagement

The Filovirus Family

The Ebola virus belongs to the Filoviridae family, which includes three genera: Cueva virus, Marburgvirus, and Ebolavirus. Within the Ebolavirus genus, six species have been identified: Zaire, Bundibugyo, Sudan, Tai Forest, Reston, and Bombali.

Transmission Routes

• Natural Hosts: Fruit bats of the Pteropodidae family likely harbour the virus.
• Animal-to-Human Transmission: Close contact with infected animals (fruit bats, chimpanzees, gorillas, etc.) or their bodily fluids.
• Human-to-Human Transmission: Direct contact with blood, body fluids, or contaminated objects from infected individuals.
• Healthcare Workers: Infection risk during patient care without strict precautions.
• Burial Ceremonies: Contact with deceased bodies contributes to transmission.

The Dance of Viral Replication

1. Efficient Replication: Ebola replicates vigorously in monocytes, macrophages, dendritic cells, and other cells.
2. Cell Necrosis: Infected cells undergo necrosis, leading to blood leakage, immune system disruption, and organ failure.

Clinical Picture

• Early Symptoms: Fever, fatigue, headache, joint pain, sore throat, cough.
• Progression: Vomiting, diarrhea, rash, unexplained bruising, internal and external bleeding, weight loss.
• Complications: Joint problems, hair loss, extreme weakness, liver inflammation, sensory changes, jaundice.
• Fatal Complications: Multiple organ failure, delirium, shock, seizures, severe bleeding, coma.
• 
  
  
  

Diagnosis and Treatment

• Diagnostic Tools: Real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA).
• Supportive Care: No specific antiviral treatment; focus on maintaining blood pressure and oxygen levels.
• Monoclonal Antibodies: mAb114 (Ansuvimab; Ebanga) and REGN-EB3 (Inmazeb) show promise.

Prevention Strategies

• Vaccination: Protect against specific Ebola types.
• Hygiene: Strict personal hygiene, avoiding infected areas, thorough cooking of animal products.
• Community Engagement: Vital for outbreak control.

Conclusion

Understanding the pathophysiology of Ebola virus disease is crucial for effective prevention, early detection, and improved patient outcomes. Let’s continue our collective efforts to combat this deadly virus and protect global health.